Partial responders to intravenous corticosteroids at day 3 benefit from continued therapy in acute severe ulcerative colitis.
- DOI
- 10.1038/s41598-026-50171-4
- Published
- 2026 Apr 30
- Container
- Scientific reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-026-50171-4,
title = {Partial responders to intravenous corticosteroids at day 3 benefit from continued therapy in acute severe ulcerative colitis.},
author = {Singh A and Bhardwaj A and Sharma R and Singh D and Jain D and Bansal N and Sebastian S and Peyrin-Biroulet L and Midha V and Sood A},
year = {2026},
journal = {Scientific reports},
doi = {10.1038/s41598-026-50171-4},
url = {https://doi.org/10.1038/s41598-026-50171-4}
}RIS
TY - JOUR TI - Partial responders to intravenous corticosteroids at day 3 benefit from continued therapy in acute severe ulcerative colitis. AU - Singh A AU - Bhardwaj A AU - Sharma R AU - Singh D AU - Jain D AU - Bansal N AU - Sebastian S AU - Peyrin-Biroulet L AU - Midha V AU - Sood A PY - 2026 JO - Scientific reports DO - 10.1038/s41598-026-50171-4 UR - https://doi.org/10.1038/s41598-026-50171-4 ER -
APA
A, S., A, B., R, S., D, S., D, J., N, B., S, S., L, P., V, M., & A, S. (2026). Partial responders to intravenous corticosteroids at day 3 benefit from continued therapy in acute severe ulcerative colitis.. Scientific reports. https://doi.org/10.1038/s41598-026-50171-4
Source records
- pubmed · retrieved 2026-09-26T22:40:17.633Z